Chance Alvarado

Chance Alvarado

Auto-generated profile, based on publicly available information

Chance Alvarado

The Ohio State University Wexner Medical Center

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2026 in Translational Pediatrics
Verified
Journal Article
Open access
AOAngela C. Onorato
Angela C. Onorato
RGRachel Gosselin
Rachel Gosselin
BCBimal Chaudhari
Bimal Chaudhari
CAChance Alvarado
Chance Alvarado
PWPeter White
Peter White
ABAmee M. Bigelow
Amee M. Bigelow
Genetic testing guidelines for children in cardiac intensive care units (CICUs) remain limited despite a high prevalence of genetic diseases among this population. Advances in next-generation sequencing technologies, especially exome sequencing (ES) and genome sequencing (GS), enable more comprehensive genetic evaluations than traditional testing modalities such as chromosomal microarray (CMA). While testing recommendations exist for cardiomyopathies and arrhythmias, broad application of next-generation sequencing, especially ES/GS, across indications for admission to CICU has not been recommended amongst cardiology societies. We aimed to evaluate the diagnostic efficacy of ES/GS in critically ill pediatric patients with cardiac disease. Retrospective chart review of patients who underwent clinical ES/GS in a quaternary hospital’s pediatric CICU between January 2020 and August 2023. Patient demographics and clinical characteristics were collected and analyzed. Results were compared by test type, cardiac phenotype, and extracardiac anomalies status. Forty-five patients underwent clinical ES/GS, with median age at testing of 33 [7–905] days. Primary cardiac phenotypes included congenital heart disease (CHD), ventricular dysfunction, and arrhythmia. Diagnostic results were found in 20 patients (44.4%) with 18/20 (90%) linked to cardiac phenotypes. Diagnostic yield was not different among cardiac phenotype groups but was higher in patients with extracardiac anomalies. Notably, gene panels would have failed to make 36% of diagnoses made by ES/GS. ES and GS provided high diagnostic yield in critically ill cardiac patients across various phenotypes. As next-generation sequencing technologies and interpretation capabilities mature, diagnostic abilities in pediatric cardiac disease will continue to advance.

2 February 2026 in Journal of Perinatology
Verified
Journal Article
Open access
SSStephanie L. Santoro
Stephanie L. Santoro
CAChance Alvarado
Chance Alvarado
STStephanie Y. Tseng
Stephanie Y. Tseng
SCSara Conroy
Sara Conroy
IKIsaac Kistler
Isaac Kistler
CCClifford L. Cua
Clifford L. Cua
Objective: In 2022, the U.S. Supreme Court decision on Dobbs v. Jackson Women’s Health Organization changed abortion access. We evaluated birth rates of Down syndrome (DS) before and after the Dobbs decision hypothesizing similarity to cyanotic congenital heart disease. Study design: Retrospective cohort study of live births utilizing 2016 – 2025 CDC birth certificate registry data stratified by DS and by state abortion access categories (restrictive and protective) based on the Guttmacher Institute. Incidence of DS and the difference in incidence between state cohorts were modeled and compared between pre- and post-Dobbs periods using segmented linear regression. Results: Incidence of DS live births remained stable in restrictive and protective states pre- and post-Dobbs. Segmented regression models revealed no significant changes in monthly incidence in the post-Dobbs era nationally compared to pre-Dobbs. Conclusions: Mean monthly incidence of DS in live-born infants using CDC birth certificate data did not increase after the Dobbs decision.

4 July 2026 in Pediatric Cardiology
Verified
Journal Article
Open access
PCPhillip S. Cheng
Phillip S. Cheng
JWJonathan A. Wheeler
Jonathan A. Wheeler
AWAaron T. Walsh
Aaron T. Walsh
CAChance R. Alvarado
Chance R. Alvarado
KHKan N. Hor
Kan N. Hor
ATAndrew H. Tran
Andrew H. Tran
Dyslipidemia is associated with increased risk for atherosclerosis and cardiovascular events in adulthood. Atherosclerosis begins in childhood and guidelines exist to screen for at-risk children. Children with congenital heart disease (CHD) have high lifetime cardiovascular risk but data are limited on their rates of dyslipidemia. Our study aims to detail rates of lipid screening and dyslipidemia in children with CHD. Children with CHD aged 9–18 years who followed at our institution from 2012 to 2019 were included. Subjects were classified as dyslipidemic if they met one of the following: total cholesterol ≥ 200 mg/dL, low-density lipoprotein-C ≥ 130 mg/dL, triglycerides ≥ 130 mg/dL, high-density lipoprotein cholesterol [HDL-C] < 40 mg/dL, non-HDL-C ≥ 145 mg/dL. Of 1579 patients, only 11.3% ( N = 179/1579) had a documented lipid panel. Of those screened, 60% ( N = 107/179) had dyslipidemia. Screened subjects had higher median BMI percentiles versus unscreened (84th vs. 64th ). Dyslipidemic subjects had higher median BMI percentiles compared to those without (92nd vs. 74th ). Black patients were a higher proportion of the screened population compared to unscreened (26% vs. 11%). Overall, there were similar rates of dyslipidemia across all races and CHD lesions. Only a small proportion of children with CHD had lipid screening performed despite universal screening guidelines. However, a sizable percentage of children screened had dyslipidemia. Screening favored Black patients and those with higher BMI. Higher BMI patients had increased rates of dyslipidemia. These findings emphasize the importance of universal screening for dyslipidemia in children with CHD.

15 September 2026 in World Journal for Pediatric and Congenital Heart Surgery
Verified
Journal Article
Closed access
MCMargarita Camacho
Margarita Camacho
CYCan Yerebakan
Can Yerebakan
PMPatrick McConnell
Patrick McConnell
MGMark Galantowicz
Mark Galantowicz
CDCassandra L. Davidson
Cassandra L. Davidson
SCSergio A. Carrillo
Sergio A. Carrillo
Purpose: To characterize the clinical characteristics, surgical experience, and long-term outcomes of patients with Kabuki syndrome (KS) and congenital heart disease (CHD). Methods: We performed a retrospective single-center review of 37 pediatric patients with KS evaluated between January 2000 and January 2025. Among these, 18 patients had CHD and were categorized according to whether cardiac surgery was required. Demographic characteristics, cardiac diagnosis, surgical procedures, perioperative risk factors and complications, survival, and follow-up data were analyzed. Results: Of the 37 patients with KS, 18(49%) had CHD. The most frequent diagnoses were bicuspid aortic valve, hypoplastic left heart syndrome, and coarctation of the aorta. Eleven of 18 patients (61%) underwent cardiac surgery, whereas 7 of 18 (39%) did not require surgical intervention. Among 19 procedures performed, Hybrid Stage I palliation was the most common (n = 5), followed by atrial septectomy, Fontan procedure, and coarctectomy (n = 3 each). Perioperative morbidity was concentrated among patients with complex cardiac anatomy and significant KS-associated extracardiac comorbidities. Four of 11 surgical patients (36%) died during the index hospitalization, predominantly those with single-ventricle physiology. No deaths occurred among patients managed without surgical intervention, and no late mortality was observed during follow-up. Conclusion: Durable long-term survival is achievable in patients with KS and CHD who survive the early postoperative period. Although perioperative morbidity and mortality were concentrated among patients with complex cardiac anatomy, outcomes also appeared to be influenced by KS-associated extracardiac comorbidities, supporting individualized surgical decision-making and multidisciplinary perioperative care .

23 July 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
WFWilliam M. Fogarty
William M. Fogarty
CPChristina Phelps
Christina Phelps
MGMark Galantowicz
Mark Galantowicz
CAChance Alvarado
Chance Alvarado
RARobin Alexander
Robin Alexander
AAAimee K. Armstrong
Aimee K. Armstrong
The optimal timing of a balloon atrial septostomy (BAS) in patients with hypoplastic left heart syndrome (HLHS) undergoing hybrid stage 1 (HS1) palliation is unknown. We hypothesized that concomitant completion of the BAS and HS1 would decrease hospital stay, increase intensive care unit-free days, improve hemodynamic markers, and increase transplant-free survival. We retrospectively reviewed HLHS patients palliated with HS1 from January 2009 to July 2022 at our center. We excluded other single ventricle variants, those who did not have a BAS or had a BAS performed prior to the HS1, and those with an initial atrial septal intervention other than BAS. Patients were divided into 2 groups: (1) those with same-day BAS and HS1, and (2) BAS performed ≥1 day after the HS1. Twenty patients had a BAS and HS1 on the same day, and 69 patients had delayed BAS, whereas 29 patients were excluded. The same-day cohort had significantly shorter hospital length of stay, higher recorded cerebral near infrared spectroscopy troughs, and lower 30-day post-BAS/discharge brain natriuretic peptide levels. There was no difference in transplant-free survival, and a greater proportion of the same-day group required atrial septal reintervention. Although there was no difference in transplant-free survival and higher rates of atrial septal reintervention, concomitant completion of BAS and HS1 in HLHS patients demonstrated shorter HS1 hospitalization and improved hemodynamic markers.

20 August 2026 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
ASArash Salavitabar
Arash Salavitabar
DGDaniel Gruenstein
Daniel Gruenstein
CAChance Alvarado
Chance Alvarado
AKAndrew Kuhls-Gilcrist
Andrew Kuhls-Gilcrist
GHGurumurthy Hiremath
Gurumurthy Hiremath
Assessment of differential lung perfusion is currently limited to periprocedural lung perfusion scans (LPS) or magnetic resonance imaging (MRI), which do not enable for real-time decision making. This study demonstrates the development and evaluation of a novel angiographic lung perfusion (ALP) technique in patients with congenital heart disease. The ALP technique was used to analyze differential branch pulmonary artery (PA) flow in retrospectively identified PA angiograms with corresponding LPS or MRI. Intraclass correlation coefficient and agreement were assessed. Two mathematical models were tested (area under curve and slope) at 2 time points (second peak and average). Twenty-five angiograms were analyzed. The most common cardiac anatomy was tetralogy of Fallot, and most common indication for catheterization was unilateral branch PA stenosis. The slope-based methods demonstrated high intraclass correlation coefficients with LPS/MRI (ICC, 0.84-0.86), indicating good reliability (ranging moderate-to-excellent), whereas Bland-Altman analysis showed low overall bias. This ALP quantification application enables accurate lung perfusion assessment with potential for real-time integration into a fluoroscopic platform. This method provides a potential method for quantifying clinically meaningful intraprocedural information, particularly in assessing relative changes in differential perfusion before and after PA interventions. Further prospective studies are needed to confirm accuracy and clinical utility in broader populations.